Dividends & Buybacks ·
Glucotrack, Inc. held its 2026 annual meeting of stockholders on August 18, 2026, where shareholders approved a…
GCTKGlucotrack, Inc.
Glucotrack, Inc. held its 2026 annual meeting of stockholders on August 18, 2026, where shareholders approved a reverse stock split at an aggregate ratio not to exceed one-for-thirty and authorized a warrant inducement involving the repricing of existing warrants to comply with Nasdaq Listing Rule 5635(d). The company also elected six directors, ratified executive compensation on an advisory basis, and reappointed CBIZ CPAs P.C. as its independent auditor. Glucotrack operates in the medical device industry, developing continuous glucose monitoring systems.